- Home
- ARWR vs GDV Comparison
ARWR vs GDV Comparison
Compare ARWR & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- GDV
- Stock Information
- Founded
- ARWR 2003
- GDV 2003
- Country
- ARWR United States
- GDV United States
- Employees
- ARWR N/A
- GDV N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- GDV Investment Managers
- Sector
- ARWR Health Care
- GDV Finance
- Exchange
- ARWR Nasdaq
- GDV Nasdaq
- Market Cap
- ARWR 1.8B
- GDV 2.0B
- IPO Year
- ARWR 1993
- GDV N/A
- Fundamental
- Price
- ARWR $16.36
- GDV $24.89
- Analyst Decision
- ARWR Buy
- GDV
- Analyst Count
- ARWR 10
- GDV 0
- Target Price
- ARWR $42.13
- GDV N/A
- AVG Volume (30 Days)
- ARWR 1.9M
- GDV 186.0K
- Earning Date
- ARWR 05-12-2025
- GDV 01-01-0001
- Dividend Yield
- ARWR N/A
- GDV 5.81%
- EPS Growth
- ARWR N/A
- GDV N/A
- EPS
- ARWR N/A
- GDV N/A
- Revenue
- ARWR $545,209,000.00
- GDV N/A
- Revenue This Year
- ARWR $4,380.43
- GDV N/A
- Revenue Next Year
- ARWR $66.56
- GDV N/A
- P/E Ratio
- ARWR N/A
- GDV N/A
- Revenue Growth
- ARWR 1436.97
- GDV N/A
- 52 Week Low
- ARWR $9.57
- GDV $18.04
- 52 Week High
- ARWR $30.41
- GDV $23.00
- Technical
- Relative Strength Index (RSI)
- ARWR 59.58
- GDV 61.88
- Support Level
- ARWR $14.92
- GDV $24.58
- Resistance Level
- ARWR $17.19
- GDV $24.95
- Average True Range (ATR)
- ARWR 0.95
- GDV 0.36
- MACD
- ARWR 0.11
- GDV -0.00
- Stochastic Oscillator
- ARWR 70.29
- GDV 75.49
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.